Mucosal associated invariant T (MAIT) cells are evolutionarily-conserved, innate-like lymphocytes which are abundant in human lungs and can contribute to protection against pulmonary bacterial infection. MAIT cells are also activated during human viral infections, yet it remains unknown whether MAIT cells play a significant protective or even detrimental role during viral infections in vivo. Using murine experimental challenge with two strains of influenza A virus, we show that MAIT cells accumulated and were activated early in infection, with upregulation of CD25, CD69 and Granzyme B, peaking at 5 days post infection.
We have previously shown that peripheral MAIT cells are activated in vivo during human infections with influenza A virus (IAV), dengue virus and hepatitis C, whilst in vitro these viruses activate MAIT cells in an IL-18 dependent manner 20 . Moreover, we showed that activation correlated with disease activity in IAV 20 and reduced peripheral blood MAIT cell frequencies were associated with death in severe avian H7N9 IAV disease 21 
Results

MAIT cells accumulate in the lungs and are activated during influenza infection.
First, we sought to determine whether MAIT cells were activated in vivo during influenza virus infection. For these studies C57BL/6 (wild-type; WT) mice received an experimental challenge with 100 plaque forming units (PFU) of the mouse-adapted influenza virus strain A/Puerto Rico/8/34/1934 (PR8, H1N1), which causes severe pneumonia in mice, characterised by parenchymal necrosis and infiltrates of macrophages, lymphocytes and neutrophils ( Supplementary Fig 1) . We observed rapid accumulation of pulmonary MAIT cells (defined as TCRb + CD45.2 + CD19 -MR1-5-OP-RU tetramer + cells), which peaked around 5 days postinfection (dpi) (Fig.1a , mean 2.6-fold increase from baseline, P<0.0001, n=20, returning to baseline by day 7 (Fig. 1a,b ). By comparison, peak frequencies of non-MAIT ('conventional') CD8+ cells occurred later at day 7 post-infection. The proportional increase in MAIT cells was significantly higher than that of CD4+ or CD8+ cells at day 5 post-infection (P<0.001). In addition to MAIT cell recruitment, influenza A virus infection induced MAIT cell activation, as indicated by increased expression of CD25, CD69 and Granzyme B (Fig. 1c-h ). Expression of CD25 and CD69 peaked at day 5 post-infection and was significantly higher in MAIT cells than conventional CD4+ or CD8+ T cells, persisting until day 13 post-infection. By contrast, CD25 expression peaked at 7 dpi conventional CD4+ T cells, whilst CD69 continued to increase over the course of the experiment and the highest levels were detected on CD4+ and CD8+ T cells at 13 dpi. Together, these results indicate that MAIT cells accumulate and are activated early in the airways following influenza A virus infection of mice.
Accumulation and activation of MAIT cells is modulated through cytokines, independently of MR1.
We have previously demonstrated that MAIT cells can be activated by viruses independently of MR1, via IL-18 in synergy with IL-12, IL-15 or IFN-a/b 19, 20 . We therefore investigated the role of these cytokines in the accumulation and activation of MAIT cells in the lungs following influenza A virus infection, using mouse strains deficient in particular cytokines or cytokine receptors. As an additional control for MR1-mediated activation, intravenous injection was used to adoptively transfer C57BL/6 pulmonary MAIT cells into MR1 -/mice (which otherwise lack MAIT cells), as previously described 14 . Compared with WT C57BL/6 mice, the magnitude of influenza virus-induced pulmonary MAIT cell accumulation was unaffected by deficiency in IL-12, IL-15, IFN-a/b receptor (IFNaR) or MR1 ( Fig. 2a , mean 2.1-2.9-fold increases above baseline at 5 dpi), but was significantly impaired (P<0.05) by deficiency in IL-18 (mean 1.3fold increase) ( Fig. 2a ).
By contrast, MAIT cell activation (as determined by measurement of CD25 expression) was significantly impaired by deficiency of IL-15, -18 or IFNaR (showing 69%, 70% and 67% reductions in the proportion of MAIT cells expressing CD25 respectively, P<0.05 for each) and most dramatically by deficiency of IL-12 (90% decrease, P<0.0001) ( Fig. 2b) . Differences in CD69 expression were not statistically significant (Fig. 2c ). These results support the concept that in vivo, MR1-independent MAIT cell activation is driven by virus-induced proinflammatory cytokines, with a dominant role for IL-18, as previously suggested by in vitro studies 20 .
MAIT cell-deficient mice show enhanced weight loss and mortality in response to severe influenza.
Given that MAIT cells are activated and accumulate in the lungs following influenza virus infection, we sought to determine whether they might play a protective role or, conversely, enhance the inflammatory cytokine milieu and contribute to exacerbated immune pathology.
We therefore examined weight loss and survival following influenza virus infection of WT C57BL/6 mice and MR1 -/mice, which have an absolute deficiency of MAIT cells 3, 6, 24 .
Following challenge with 100 PFU of PR8 virus, MR1 -/mice exhibited greater body weight loss ( Fig. 3a ) and greater mortality (log-rank Mantel-Cox P<0.0001) ( Fig. 3b ) in comparison with WT mice. Importantly, the body weight loss and mortality in MR1 -/mice were ameliorated by i.v. adoptive transfer of pulmonary MAIT cells at 1 week prior to influenza virus infection ( Fig. 3a,b ).
We did not observe significant differences in viral load in lung homogenates prepared from PR8-infected C57BL/6 and MR1 -/mice at days 3 and 5 post-infection ( Fig. 3c ), nor in gross histology at 8 dpi (data not shown). However, MR1 -/mice had reduced numbers of SigF + CD11b int CD64 + CD11c + alveolar macrophages at 3 dpi ( Fig. 3d, P<0 .05) and reduced pulmonary T cell numbers by 5 dpi (Fig. 3e, P<0 .001). Absolute numbers of neutrophils, eosinophils, dendritic cells, NK cells and gd T cells all trended towards lower numbers in MR1 -/mice at 5 dpi, but these changes were not statistically significant ( Supplementary Fig. 2 ).
Total protein concentrations in cell-free BAL supernatants, a sensitive marker of pulmonary epithelial damage 25 , were also increased in MR1 -/mice at 5 dpi ( Fig. 3f ). These data indicate that early accumulation of MAIT cells at the site of infection protects against influenza-induced morbidity and mortality associated with excessive lung damage and recruitment of inflammatory cells, but not with viral killing.
As the mouse adapted PR8 strain is highly virulent in mice, we performed additional experiments using X-31 (H3N2, a reassortant virus bearing the hemagglutinin and neuraminidase genes from A/Aichi/2/1968 and the remaining 6 genes from PR8), a strain that shows moderate virulence in mice 25 . After intranasal infection of WT or MR1 -/mice with 5000 PFU of X-31, we did not observe significant differences in survival or in titres of infectious virus detected in the lungs ( Supplementary Fig. 3a -c), although we did observe a similar virusinduced pulmonary accumulation of MAIT cells as well as virus-induced MAIT cell activation (2.6-fold increase at 5 dpi, Supplementary Fig. 3d -g). Furthermore, following infection with both PR8 and X-31, we observed reductions in key innate inflammatory cell cytokines in lungs of MR1 -/compared with wild-type C57BL/6 mice. In particular, in MR1 -/mice we detected significantly lower levels of monocyte chemotactic protein 1 (MCP-1/CCL2) and IL-6 following infection with 100 PFU of PR8, and of RANTES/CCL5 following 5000 PFU of X-31with similar trends observed with both virus strains for each of the inflammatory mediators detected ( Supplementary Fig. 4 ).
Together, these data suggest that MAIT cells play a protective role during severe influenza virus infection, enhancing pulmonary T cell accumulation and innate inflammatory cytokine production, and reducing weight loss, mortality and pulmonary epithelial damage.
Adoptive transfer of MAIT cells delays mortality in IAV-infected immunodeficient mice
To further explore the protective role of MAIT cells during influenza infection, we studied the impact of adoptively transferred MAIT cells into immunodeficient Rag2 -/-gC -/mice lacking T cell-, B cell-and NK cell-mediated immunity. As previously described 14, 24 , ~0.3x10 6 pulmonary MAIT cells were adoptively transferred into Rag2 -/-gC -/mice. Low numbers of residual contaminating conventional T cells from the donor mice can rapidly expand in these recipient mice. Therefore, residual contaminating conventional T cells were depleted in recipients with anti-CD4 and anti-CD8 mAbs, and the animals rested for 1-2 weeks to allow expansion of the MAIT cell population prior to challenge with PR8 or X-31 strains ( Fig. 4a ).
Adoptive transfer of MAIT cells reduced weight loss ( Fig. 4b ) and significantly prolonged survival after PR8 infection ( Fig. 4c , log-rank Mantel-Cox P<0.05). In this immunocompromised Rag2 -/-gC -/mouse model adoptive transfer of MAIT cells now also provided protection following challenge with the less virulent X-31 strain ( Fig. 4d ,e, log-rank Mantel-Cox P=0.02).
Given that human MAIT cells express IFN-g in response to stimulation of TLR-8 with singlestranded RNA 19 , and also that human viral activation of MAIT cells can suppress replication of hepatitis C virus via IFN-g in vitro 20 , we hypothesised that IFN-g expression by MAIT cells could contribute to their protective role following influenza virus infection. To address whether IFN-g expression by MAIT cells confers protection against IAV in vivo, MAIT cells from wild-type C57BL/6 and from IFN-g -/donor mice were transferred into Rag2 -/-gC -/mice.
As expected, the protective effect of adoptively-transferred MAIT cells was abrogated when the transferred MAIT cells were deficient in IFN-g ( Fig. 4d,e ), suggesting that the antiviral effects provided by MAIT cells are mediated, at least in part, by IFN-g.
Discussion
We have shown in vivo that MAIT cells accumulate in the lungs, are activated and contribute to protection against morbidity and mortality during influenza virus infection in mice. These findings are consistent with our previous human in vitro observations in which we demonstrated MR1-independent MAIT cell activation in response to exogenous cytokines 19, 20 or to influenza A virus 20 . In those experiments, we co-incubated peripheral blood mononuclear cells (PBMCs) or human CD8+ T cells with virus-infected monocytes, macrophages or dendritic cells and observed strong, dose-dependent MAIT cell activation with upregulation of CD69 and IFN-g and Granzyme B 20 . We also observed virus-induced upregulation of CD69, Granzyme B and IFN-g on MAIT cells in separate experiments using co-culture of PBMC with IAV infection of a human lung epithelial cell line (A549) 21 . Here, we observed strong CD25 and CD69 upregulation by MAIT cells in the lungs of IAV-infected mice, which occurred earlier and to a greater extent than in non-MAIT CD3+ T cells, and was associated with Granzyme B upregulation, suggesting that these cells are licensed for cytotoxicity early in influenza virus infection.
In the previous in vitro studies, virus-induced responses were unaffected by anti-MR1 blocking antibody 20,21 , but rather were driven by cytokines. Indeed, this would be consistent with the MAIT cell accumulation ( Fig. 2a) and their protective effects observed after adoptively transferring MAIT cells into mice with deletion of MR1 ( Fig. 3b ). Stimulation with IL-12 and IL-18 is known to induce IFN-g from CD161 ++ CD8 + T cells, of which MAIT cells are the dominant subset in humans 19 . In both the lung epithelial cell 21 and the professional antigen presenting cell 20 co-culture systems, we found IL-18 to be the dominant activating cytokine in influenza virus infection, acting synergistically with IL-12 or IL-15 or type I interferons 20 . Again, we confirmed these observations in vivo using mice with genetic deletions of these cytokines or their receptors, and found that MAIT cell accumulation and CD69 upregulation were significantly impaired only in the IL-18 -/mice ( Fig. 2a,c) . Interestingly, CD25 activation was affected to the greatest extent by IL-12 deletion ( Fig. 2b) , likely because an important general biological function of IL-12 is to induce T cell upregulation of CD25 26 .
Our previous clinical human influenza infection studies showed activation of peripheral blood MAIT cells, measured by Granzyme B upregulation 20 and a decrease in peripheral blood MAIT cell frequencies, which correlated with disease severity 20 and with fatal outcomes 21 . In these studies, it was not possible to determine causal associations nor examine lung tissue. Our murine data recapitulated these findings and revealed activated MAIT cells at the site of infection. In human studies there are wide inter-individual variations in baseline frequencies of peripheral blood MAIT cells 4 . However, overall the observed clinical association between reduced MAIT cell frequencies and influenza mortality would be consistent with the increased mortality we observed here in MR1 -/mice.
MAIT cells are not unique in their capacity to respond to virus-induced cytokines.
Virus-induced bystander activation was first described in conventional CD8+ T cells in mice 27
but is overall a rare event in these cells 28 . However, the high IL-18R expression and IL-12/18 responsiveness appear to be common to a range of innate-like lymphocytes expressing PLZF 29 , which in humans include iNKT, gd T, and NK cells 30 . Indeed, protective roles for iNKT cells have been shown in murine IAV infection [31] [32] [33] . Nonetheless, whilst iNKT cells are relatively abundant in mice, they are quite rare in humans, constituting approximately 0.1% of peripheral blood T cells 3, 30, 34 , while in humans MAIT cells are much more abundant comprising 1-10% of blood 3 and pulmonary 4 T cells. Furthermore, at early stages the absolute numbers of these cells in the lungs will markedly exceed the numbers of conventional antigen-specific T cells responding to cognate viral antigens 34 . Furthermore, as they display a significantly higher TCR-independent upregulation of IFN-g than conventional T cells 21 , MAIT cells may have a considerable role in early antiviral protection in humans. Nevertheless, despite much lower relative frequencies of MAIT cells in mice compared with humans, it is striking that we could observe a protective effect of MAIT cells in wild-type vs MR1 -/mice on a C57BL/6 background, which had an otherwise intact immune system including all other PLZFexpressing subsets.
Although MAIT cells protected against influenza virus-induced weight loss and mortality, we did not detect a significant difference in viral titres at the time of peak viral load (i.e. 3-5 dpi). This is not unexpected, as other investigators have also observed significant differences in immunopathology without changes in IAV load 33 . Furthermore, whilst the cytokine responsiveness of MAIT cells suggests the potential for a possible deleterious role in which they could contribute to the 'cytokine storm' effect observed in severe influenza 35 , our data from both C57BL/6 and RAG2 -/-gC -/strains showed no evidence that MAIT cells contributed to enhanced immunopathology. In fact, the opposite effect was seen.
The importance of MAIT cells to immune protection in humans may be most apparent when MAIT cell frequencies are reduced. MAIT cell frequencies are lowest in early life 3 and in the elderly 36 , age groups at highest risk of influenza mortality 37 . Influenza mortality is also associated with suppressed cell-mediated immunity, including HIV infection and iatrogenic immunosuppression, conditions in which MAIT cells are also suppressed 37, 38 . Of particular relevance to respiratory viral infections, therapeutic use of inhaled and oral corticosteroids causes marked reductions in airway MAIT cell frequencies in asthma 4 and chronic obstructive pulmonary disease 5 , and thus may contribute to the increased risk of influenza hospitalisation in these conditions 39 .
Influenza virus is a major human respiratory pathogen, which causes seasonal epidemics resulting in 300-650,000 deaths annually 40 . IAV can also cause pandemic spread when novel strains emerge 37 . Although the most effective method for prevention and control of influenza is vaccination, current vaccines show limited efficacy and little heterologous protection between strains, and so require annual reformulation. The TCR-independent nature of the antiviral MAIT cell response therefore offers significant therapeutic potential in at least two ways. Firstly, strategies to target MAIT cell activation, for instance by incorporating MAIT cell ligands and TLR agonists in the formulation of novel adjuvants, could be used to enhance the efficacy of future influenza vaccines. Secondly, we have shown that MAIT cell frequencies can be rapidly 'boosted' through mucosal administration of simple synthetic MAIT cell ligands with TLR agonists 14, 24 , which may prove effective in a number of scenarios including shortterm prophylactic vaccination during an epidemic. Such a strategy may also prove beneficial in protecting groups known to show impairments in MAIT cell immunity -such as the elderly or those receiving therapeutic corticosteroids -or even acutely during the early stages of infection.
In summary, we have shown for the first time in vivo evidence of an important contribution of MAIT cells to protective immunity against a major human viral pathogen. As the cytokine-mediated activation of MAIT cells is a mechanism likely to be common to a number of other acute and chronic viral infections, as has already been shown in dengue virus, hepatitis C virus in clinical studies 20,23 , these findings from an influenza model are likely to be widely applicable to a range of respiratory and systemic viral diseases.
Methods
Animal models
Mice were bred and housed in the Biological Research Facility of the Peter Doherty Institute (Melbourne, Victoria, Australia). MR1 -/mice were generated by breeding Va19iCa -/-MR1 -/mice 41 performed on isofluorane-anesthetized mice. Virus stocks were grown in the allantoic cavity of 10 day-old embryonated chicken eggs, and the viral titre was determined by a plaque assay on MDCK monolayers, as previously described 42 .
Mice were weighed daily and assessed for visual signs of clinical disease. Animals that lost ≥20% of their original body weight and/or displayed evidence of pneumonia were euthanized.
Mice were killed by CO 2 asphyxia, the heart perfused with 10 ml cold RPMI and lungs were taken. To prepare single-cell suspensions lungs were finely chopped with a scalpel blade and treated with 3 mg/ml collagenase III (Worthington, Lakewood, NJ), 5 µg/ml DNAse, and 2% foetal calf serum in RPMI for 90 min at 37°C with gentle shaking. Cells were then filtered (70 µm) and washed with PBS/2% foetal calf serum. For plaque assays lungs were placed into RPMI and homogenised using a Polytron System PT 1200 CL 230V (Kinematica, Lucerne, Switzerland). Red blood cells were lysed with hypotonic buffer TAC (Tris-based amino chloride) for 5 min at 37°C. Approximately 1.5x10 6 cells were filtered (40 µm) and used for flow cytometric analysis.
Determination of viral load counts in infected lungs.
Viral load was determined by counting plaque-forming units (PFU) in MDCK monolayers
infected with lung homogenates, at varying dilutions for 45 mins at 37°C, 5% CO 2 before the addition of an Agarose/L15 or MEM overlay containing Trypsin (Worthington Biochemical, NJ, USA), as described 42 . Plates were incubated at 37°C, 5% CO 2 for 3 days before plaques were counted.
Adoptive transfer
As MAIT cell numbers are low in naïve C57BL/6 mice, prior to adoptive transfer experiments MAIT cell populations were expanded by intranasal infection with 10 6 CFU S. Typhimurium BRD509 in 50 µl PBS for 7 days, as described 24 . After 7 days, mice were sacrificed, singlecell suspensions prepared and live CD3+CD45+MR1-5-OP-RU tetramer+ cells sorted using a BD FACS Aria III. 3x10 5 
